Abstract
Drug resistance in Mycobacterium leprae is a significant problem in countries where leprosy is endemic. A sensitive, specific, and high-throughput reverse blot hybridization assay (REBA) for the detection of genotypic resistance to rifampicin (RIF) was designed and evaluated. It has been shown that resistance to RIF in M. leprae involves mutations in the rpoB gene encoding the —subunit of the RNA polymerase. The PCR-REBA simultaneously detects both 6 wild-type regions and 5 different mutations (507AGC, 513GTG, 516TAT, 531ATG, and 531TTC) including the most prevalent mutations at positions 507 and 531. Thirty-one clinical isolates provided by Korea Institute of Hansen-s Disease were analyzed by PCR-REBA with RIF resistance of rpoB gene. As a result, missense mutations at codons 507 AGC and 531ATG with 2-nucleotide substitutions were found in one sample, and a missense mutation at codon 516 TAT and ΔWT6 (deletion of 530-534) was found in another sample. These cases were confirmed by DNA sequence analysis. This rapid, simple, and highly sensitive assay provides a practical alternative to sequencing for genotypic evaluation of RIF resistance in M. leprae.
Similar content being viewed by others
References
Ahmed, A., Engelberts, M.F., Boer, K.R., Ahmed, N., and Hartskeerl, R.A. 2009. Development and validation of a real-time PCR for detection of pathogenic leptospira species in clinical materials. PLoS One 4, e7093.
de Carsalade, G.Y., Wallach, D., Spindler, E., Pennec, J., Cottenot, F., and Flageul, B. 1997. Daily multidrug therapy for leprosy; results of a fourteen-year experience. Int. J. Lepr. Other. Mycobact. Dis. 65, 37–44.
Cambau, E., Chauffour-Nevejans, A., Tejmar-Kolar, L., Matsuoka, M., and Jarlier, V. 2012. Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test. PLoS. Negl. Trop. Dis. 6, e1739.
Cavusoglu, C., Hilmioglu, S., Guneri, S., and Bilgic, A. 2002. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J. Clin. Microbiol. 40, 4435–4438.
Choi, G.E., Lee, S.M., Yi, J., Hwang, S.H., Kim, H.H., Lee, E.Y., Cho, E.H., Kim, J.H., Kim, H.J., and Chang, C.L. 2010. High-resolution melting curve analysis for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates. J. Clin. Microbiol. 48, 3893–3898.
Groathouse, N.A., Rivoire, B., Kim, H., Lee, H., Cho, S.N., Brennan, P.J., and Vissa, V.D. 2004. Multiple polymorphic loci for molecular typing of strains of Mycobacterium leprae. J. Clin. Microbiol. 42, 1666–1672.
Gupta, U.D., Katoch, K., and Katoch, V.M. 2009. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era. Indian J. Lepr. 81, 131–134.
Ji, B. and Grosset, J. 2000. Combination of rifapentine-moxifloxacinminocycline (PMM) for the treatment of leprosy. Lepr. Rev. 71, S81–87.
Ji, B., Perani, E.G., Petinon, C., and Grosset, J.H. 1992. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice. Int. J. Lepr. Other Mycobact. Dis. 60, 556–561.
Ji, B., Sow, S., Perani, E., Lienhardt, C., Diderot, V., and Grosset, J. 1998. Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients. Antimicrob. Agents Chemother. 42, 1115–1120.
Jing, Z., Zhang, R., Zhou, D., and Chen, J. 2009. Twenty five years follow up of MBleprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy. Lepr. Rev. 80, 170–176.
Katoch, V.M. 2002. Advances in the diagnosis and treatment of leprosy. Expert. Rev. Mol. Med. 4, 1–14.
Kramme, S., Bretzel, G., Panning, M., Kawuma, J., and Drosten, C. 2004. Detection and quantification of Mycobacterium leprae in tissue samples by real-time PCR. Med. Microbiol. Immunol. 193, 189–193.
Maeda, S., Matsuoka, M., Nakata, N., Kai, M., Maeda, Y., Hashimoto, K., Kimura, H., Kobayashi, K., and Kashiwabara, Y. 2001. Multidrug resistant Mycobacterium leprae from patients with leprosy. Antimicrob. Agents Chemother. 45, 3635–3639.
Matsuoka, M., Aye, K.S., Kyaw, K., Tan, E.V., Balagon, M.V., Saunderson, P., Gelber, R., Makino, M., Nakajima, C., and Suzuki, Y. 2008. A novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries. J. Med. Microbiol. 57, 1213–1219.
Matsuoka, M., Budiawan, T., Aye, K.S., Kyaw, K., Tan, E.V., Cruz, E.D., Gelber, R., Saunderson, P., Balagon, V., and Pannikar, V. 2007. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines. Lepr. Rev. 78, 343–352.
Matsuoka, M., Suzuki, Y., Garcia, I.E., Fafutis-Morris, M., Vargas-Gonz- lez, A., Carre- o-Martinez, C., Fukushima, Y., and Nakajima, C. 2010. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico. Jpn. J. Infect. Dis. 63, 412–416.
Matsuoka, M., Suzuki, Y., and Makino, M. 2010. Novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries. Nihon. Hansenbyo. Gakkai. Zasshi. 79, 257–261.
Mokrousov, I., Bhanu, N.V., Suffys, P.N., Kadival, G.V., Yap, S.F., Cho, S.N., Jordaan, A.M., Narvskaya, O., Singh, U.B., Gomes, H.M., et al. 2004. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. J. Microbiol. Methods 57, 323–335.
Morgan, M., Kalantri, S., Flores, L., and Pai, M. 2005. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and metaanalysis. BMC Infect. Dis. 5, 62.
Rodrigues, L.C. and Lockwood, D. 2011. Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect. Dis. 11, 464–470.
Sapkota, B.R., Ranjit, C., Neupane, K.D., and Macdonald, M. 2008. Development and evaluation of a novel multiple-primer PCR amplification refractory mutation system for the rapid detection of mutations conferring rifampicin resistance in codon 425 of the rpoB gene of Mycobacterium leprae. J. Med. Microbiol. 57, 179–184.
Sekar, B., Arunagiri, K., Kumar, B.N., Narayanan, S., Menaka, K., and Oommen, P.K. 2011. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing-a rapid tool for screening drug resistance in leprosy. Lepr. Rev. 82, 36–45.
Shetty, V.P., Wakade, A.V., Ghate, S., Pai, V.V., Ganapati, R., and Antia, N.H. 2003. Viability and drug susceptibility testing of M. leprae using mouse footpad in 37 relapse cases of leprosy. Int. J. Lepr. Other Mycobact. Dis. 71, 210–217.
Suzuki, Y. and Matsuoka, M. 2006. DNA microarray based rapid drug susceptibility test for Mycobacterium leprae. Nihon. Hansenbyo. Gakkai. Zasshi. 75, 271–277.
World Health Organization. 2013. Global tuberculosis report. http://www.who.int/tb/publications/global_report/en/. World Health Organization (ed.) Appia, Geneva, Switzerland: WHO Press, 2013.
You, E.Y., Kang, T.J., Kim, S.K., Lee, S.B., and Chae, G.T. 2005. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea. J. Infect. 50, 6–11.
Zhang, L., Namisato, M., and Matsuoka, M. 2004. A mutation at codon 516 in the rpoB gene of Mycobacterium leprae confers resistance to rifampin. Int. J. Lepr. Other Mycobact. Dis. 72, 468–472.
de Zwaan, R., van Ingen, J., van Soolingen, D. 2014. Utility of rpoB gene sequencing for identification of nontuberculous mycobacteria in the Netherlands. J. Clin. Microbiol. 52, 2544–2551.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, Hy., Kim, H., Kim, Y. et al. Performance of PCR-reverse blot hybridization assay for detection of rifampicin-resistant Mycobacterium leprae . J Microbiol. 53, 686–693 (2015). https://doi.org/10.1007/s12275-015-5057-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-015-5057-9